Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, Tanaka Y, Yagi H, Sonoda K, Kai M, Kanoh H, Nakano H, Mekada E.
Miyamoto S, et al. Among authors: tanaka y.
Cancer Res. 2004 Aug 15;64(16):5720-7. doi: 10.1158/0008-5472.CAN-04-0811.
Cancer Res. 2004.
PMID: 15313912